share_log

TD Cowen Initiates Coverage On Viridian Therapeutics With Buy Rating

Benzinga ·  06:09

TD Cowen analyst Joseph Thome initiates coverage on Viridian Therapeutics (NASDAQ:VRDN) with a Buy rating.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment